Twinlet 250mg/31.25mg Injection
Marketer
Medopharm
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Twinlet 250mg/31.25mg Injection
Combiflox 250 mg/31.25 mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration should be strictly under medical guidance. Consistent adherence to the prescribed dosage is crucial; premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require urgent medical care. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals require specific medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Your physician may order tests to monitor therapeutic response.
Primary Ingredients of Twinlet 250mg/31.25mg Injection
There is no text provided to rephrase.
Uses of Twinlet 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Twinlet 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Twinlet 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Twinlet 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Twinlet 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Twinlet 250 mg/31.25 mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Twinlet 250 mg/31.25 mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Twinlet 250 mg/31.25 mg is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Twinlet 250 mg/31.25 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Twinlet 250 mg/31.25 mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Twinlet 250 mg/31.25 mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Twinlet (250 mg/31.25 mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Twinlet (250 mg/31.25 mg) injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Twinlet 250mg/31.25mg Injection :
Should you forget a dose of Twinlet 250 mg/31.25 mg Injection, seek your physician's advice.
Facts to Know About Twinlet 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently